Analytical Data
-
Gene name
SAMEA2071181_01128
- Application
-
Species
Mycobacteroides abscessus subsp. abscessus
-
Source
E. coli
-
Tag
N- His & C- Myc
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
A0A1N3W156
-
Expression Region
1-92aa
-
Molecular Weight
18.0 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
SAMEA2071181_01128 is a recombinant protein that has garnered interest in the field of molecular biology and biotechnology due to its potential applications in therapeutic development and diagnostic tools. The study of this protein stems from its association with specific cellular pathways, which are crucial for understanding various biological processes, including cell signaling, immune response, and disease progression. Researchers are particularly focused on elucidating the structure-function relationship of SAMEA2071181_01128, as this knowledge could enable the design of targeted therapies for diseases where these pathways are dysregulated. Moreover, the ability to produce this protein in a recombinant form allows for detailed biochemical characterization and functional assays, facilitating the investigation of its interactions with other biomolecules. The growing body of evidence suggests that SAMEA2071181_01128 could serve as a valuable biomarker in diagnosing certain conditions or as a therapeutic target in disease management. Consequently, ongoing studies aim to explore its functional roles and investigate how modifications of the protein might enhance its therapeutic efficacy. This research is critical for advancing our understanding of the underlying mechanisms of diseases and developing innovative strategies for treatment.
